Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Oethinger

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Infection|December 23, 1998
Colonization and infection with fluoroquinolone-resistant Escherichia coli among cancer patients: clonal analysisM Oethinger, A S Jellen-Ritter, S Conrad, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1994
Emergence of fluoroquinolone-resistant Escherichia coli at a cancer centerW V Kern, E Andriof, M Oethinger, et al.
Thrombosis and Haemostasis|April 1, 1993
Influence of acute myocardial infarction and rt-PA therapy on circulating fibrinogenE Seifried, M Oethinger, P Tanswell, et al.
Acta Orthopaedica Scandinavica|June 1, 1997
Autotransfusion--bacterial contamination during hip arthroplasty and efficacy of cefuroxime prophylaxis. A randomized controlled study of 40 patientsK H Wollinsky, M Oethinger, M Büchele, et al.
Letters in Applied Microbiology|May 7, 2009
Unsuitable distinction between viable and dead Staphylococcus aureus and Staphylococcus epidermidis by ethidium bromide monoazideH Kobayashi, M Oethinger, M J Tuohy, et al.
Antimicrobial Agents and Chemotherapy|December 22, 1999
Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pumpM Oethinger, W V Kern, A S Jellen-Ritter, et al.
Beitrage Zur Infusionstherapie Und Transfusionsmedizin = Contributions to Infusion Therapy and Transfusion Medicine|January 1, 1996
Influence of hemodilution on cefuroxime levels and bacterial contamination of intra- and postoperative processed wound blood during hip replacementK H Wollinsky, M Büchele, M Oethinger, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1996
Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centersM Oethinger, S Conrad, K Kaifel, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 17, 2005
Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemiaW V Kern, K Klose, A S Jellen-Ritter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2009
Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic areaJ Cuellar-Rodriguez, R K Avery, M Lard, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Infection|December 23, 1998
Colonization and infection with fluoroquinolone-resistant Escherichia coli among cancer patients: clonal analysisM Oethinger, A S Jellen-Ritter, S Conrad, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1994
Emergence of fluoroquinolone-resistant Escherichia coli at a cancer centerW V Kern, E Andriof, M Oethinger, et al.
Thrombosis and Haemostasis|April 1, 1993
Influence of acute myocardial infarction and rt-PA therapy on circulating fibrinogenE Seifried, M Oethinger, P Tanswell, et al.
Acta Orthopaedica Scandinavica|June 1, 1997
Autotransfusion--bacterial contamination during hip arthroplasty and efficacy of cefuroxime prophylaxis. A randomized controlled study of 40 patientsK H Wollinsky, M Oethinger, M Büchele, et al.
Letters in Applied Microbiology|May 7, 2009
Unsuitable distinction between viable and dead Staphylococcus aureus and Staphylococcus epidermidis by ethidium bromide monoazideH Kobayashi, M Oethinger, M J Tuohy, et al.
Antimicrobial Agents and Chemotherapy|December 22, 1999
Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pumpM Oethinger, W V Kern, A S Jellen-Ritter, et al.
Beitrage Zur Infusionstherapie Und Transfusionsmedizin = Contributions to Infusion Therapy and Transfusion Medicine|January 1, 1996
Influence of hemodilution on cefuroxime levels and bacterial contamination of intra- and postoperative processed wound blood during hip replacementK H Wollinsky, M Büchele, M Oethinger, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1996
Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centersM Oethinger, S Conrad, K Kaifel, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 17, 2005
Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemiaW V Kern, K Klose, A S Jellen-Ritter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2009
Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic areaJ Cuellar-Rodriguez, R K Avery, M Lard, et al.
Pageof 2